In conclusion, we demonstrated that poly(I:C)-driven TLR3 activation is effective for the MSCs grown as 3D spheroids and can be employed as a combinational approach to increase the post-engraftment survival of MSCs, along with their immunomodulatory and pro-regenerative potential for IBD treatment. The gene discussed is TLR3; the disease is inflammatory bowel disease.